No Data
No Data
No Data
No Data
No Data
BOC International: Maintaining Kingsley Biotech's (01548) “Buy” Rating Target Price of HK$27.75
Kingsley Biotech (01548) guides strong annual revenue growth of 15%-20% and 20%-30% (@CER, i.e. Comparative Effects Study).
Zhitong FinanceApr 24 22:53 ET
Kingsley Biotechnology (01548.HK): The European Commission approved CARVYKTI for second-line treatment of patients with recurrent refractory multiple myeloma
Gelonghui, April 23 | Kingsley Biotech (01548.HK) issued an announcement. On April 22, 2024, Legend Biotech issued a press release announcing that the European Commission (EC) approved CARVYKTI (ciltacabtagene autoleucel, cilta-cel) for the treatment of adult patients with recurrent and refractory multiple myeloma. These patients have received at least one treatment in the past, including proteasome inhibitors (PI) and immunomodulators (IMID). The patients showed disease progression during the last treatment , and lenalidomide is difficult to treat
Gelonghui FinanceApr 22 20:31 ET
金斯瑞生物科技:2023年度報告
Futu NewsApr 22 08:25 ET · Announcements
Kingsley Biotechnology (1548.HK): Global layout, business blossoming, innovative drug business entering a commercialization period
Under the intertwined influence of the risk factors of globalization, how can enterprises persevere and continue to move forward in the midst of turbulence has become a common problem in the industry. However, Kingsley seemed to have given his own unique answer with an excellent questionnaire.
Gelonghui FinanceApr 22 02:17 ET
Trending Industry Today: GENSCRIPT BIO Leads Losses In Pharmaceutical Outsourcing/contract Research Organization(cro Concept) Stocks
April 19th - The industry of $Pharmaceutical Outsourcing/contract Research Organization(cro Concept)(BK1261.HK)$ is trending lower today with 9 constituents down and GENSCRIPT BIO leading Losses.$GENS
moomoo NewsApr 19 03:50 ET
Changes in Hong Kong stocks | CRO concept stocks continue to decline, the Federal Reserve does not rule out possible interest rate hikes, domestic innovative drugs are still in an adjustment cycle
The Zhitong Finance App learned that CRO concept stocks continued to decline. As of press release, Tiger Pharmaceuticals (03347) fell 7.94% to HK$28.4; Kingsley Biotech (01548) fell 5.93% to HK$10.78; Kanglong Chemical (03759) fell 4.83% to HK$8.47; and Pharmaceuticals (02359) fell 4.5% to HK$32.9. According to the news, overnight, Federal Reserve officials made hawkish remarks. New York Federal Reserve Chairman Williams said that if the data reminds us that we need to raise interest rates to achieve our goals, then we will obviously do it. Furthermore, Asia
Zhitong FinanceApr 18 22:55 ET
No Data
No Data